Vaccine platform technologies
Rapid vaccine development
Using platform technologies for the rapid development of vaccines.
AVRA will embrace recent advances in gene and protein-based approaches for vaccination. Such advances include DNA and RNA vaccines, virus-like particles, recombinant subunit proteins, bacterial reverse vaccinology and surface-omics that are utilised and optimised for vaccine development.